The Clinical Diagnostics program offers clients unique insights into the competitive dynamics of the market, including coverage of sectors, such as molecular diagnostics, point-of-care testing, and in vitro diagnostics, from a regional and global perspective. Based on both quantitative and qualitative information, clients can leverage this information to stay abreast of challenges and trends, and to remain competitive and grow their businesses.
| Title |
Published |
Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market, Forecast to 2021
Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth
|
20 Jun 2017
|
Growth Opportunities in the APAC IVD Market, Forecast to 2021
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market
|
19 Jun 2017
|
|
North America; Technology Leadership Award - Personalized Knee Implants
|
17 Jun 2017
|
Internet of Medical Things, Forecast to 2021
Growth Opportunities, Challenges, and Future Perspectives in Healthcare
|
06 Jun 2017
|
|
Global; Technology Innovation Award - Antibody Based Cancer Therapy Industry
|
31 May 2017
|
|
North America; Technology Innovation Award - Clinical Genomic Interpretation Software
|
31 May 2017
|
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021
Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth
|
31 May 2017
|
Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021
US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation
|
23 May 2017
|
Respondents Show Significant Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications
2016 Global Survey on Clinical Next-generation Sequencing
|
05 May 2017
|
Future of Diabetes Care Paradigms, Forecast to 2022
Innovations to Disrupt Diabetes Wellness, Diagnosis, Monitoring, and Therapy
|
31 Mar 2017
|
